Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05889624 · ClinicalTrials.gov registry record · NA

Responding With Evidence and Access for Childhood Headaches

A NA study of Migraine and Headache, sponsored by Children's Hospital Medical Center, Cincinnati.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
15
Study locations

NCT05889624 is a NA study of Migraine and Headache that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 400 participants, above the 354-participant average among 102 other Migraine trials with a reported enrollment target (13% higher). The trial reports 15 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05889624, a NA study of Migraine and Headache, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
15
Study locations

Study Summary

This comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world care, and will demonstrate the feasibility of Cognitive Behavioral Therapy (CBT) via telehealth for youth with migraine. The focus is on applying evidence-based care and enhancing access to it. CBT via telehealth while taking a clinically-prescribed, pill-based prevention therapy (amitriptyline) will be compared to CBT via telehealth alone.

Conditions Studied

Migraine Headache Migraine Disorders Chronic Migraine Headache, Migraine Migraine With Aura Migraine Without Aura Headache Disorders

Interventions

  • BEHAVIORAL CBT
  • DRUG Amitriptyline

Study Locations (15)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati
  • Nationwide Childrens - Columbus

Alabama

  • University of Alabama at Birmingham Children's of Alabama - Birmingham

Arizona

  • Phoenix Children's Hospital - Barrow Neurological Institute - Phoenix

California

  • University of California San Francisco - San Francisco

Colorado

  • University of Colorado/Children's Hospital Colorado - Aurora

Delaware

  • Nemours Children's Health System - Wilmington

Georgia

  • Clinical Integrative Research Center of Atlanta, Inc - Atlanta

Kentucky

  • University of Louisville Health/Norton - Louisville

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2023-08-22
Est. Completion 2027-12-31
Phase NA

Sponsor

Children's Hospital Medical Center, Cincinnati

571 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05889624

The ClinicalTrials.gov registry entry for NCT05889624 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 354-participant average among 102 other Migraine trials with a reported enrollment target (13% higher). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Migraine appearing as the primary indexed condition, and to 2 interventions - of which CBT is the first listed.

NCT05889624 reports 15 study locations spanning 14 distinct geographic areas - top geographies include Ohio, Alabama, Arizona.

Frequently Asked Questions

What is clinical trial NCT05889624 about?

NCT05889624 is a clinical study titled "Responding With Evidence and Access for Childhood Headaches". This comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world care, and will demonstrate the feasibility of Cognitive Behavioral Therapy (CBT) via telehealth for you...

What is the current status of trial NCT05889624?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-08-22. Estimated completion is 2027-12-31.

What conditions does trial NCT05889624 study?

This clinical trial studies the following conditions: Migraine, Headache, Migraine Disorders, Chronic Migraine, Headache, Migraine.

What interventions are being tested in trial NCT05889624?

The interventions under investigation include: CBT (BEHAVIORAL), Amitriptyline (DRUG).

Who is sponsoring clinical trial NCT05889624?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05889624 being conducted?

This trial has 15 study locations across Alabama, Arizona, California, Colorado, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Migraine

All registered trials for this condition

Headache

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.